Related Experiment Video
Updated: Mar 3, 2026
11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
11.5K
Cancer Immunotherapy with Cytokine-Induced Killer Cells
Juan J Mata-Molanes1, Manuel Sureda González2, Belén Valenzuela Jiménez2
1Plataforma de Oncología, Hospital Quirónsalud Torrevieja, Alicante, Spain. juan.mata@quironsalud.es.
Targeted Oncology
|May 6, 2017
Summary
Cytokine-induced killer (CIK) cells, a mix of T and NK cells, show potent anti-tumor activity. Clinical trials confirm their efficacy in various cancers, including advanced stages.
Area of Science:
- Immunology
- Cancer Biology
- Cell Therapy
Background:
- Cytokine-induced killer (CIK) cells are derived from peripheral blood mononuclear cells (PBMCs).
- CIK cells are characterized by a mixed T-cell and Natural Killer (NK) cell phenotype (CD3+CD56+).
- Their high proliferation rate and significant anti-tumor activity make them promising for cancer immunotherapy.
Purpose of the Study:
- To review the biological and technical aspects of CIK cell generation and function.
- To summarize current clinical trials investigating CIK cell immunotherapy for various neoplasms.
- To discuss future trends and potential applications of CIK cell therapy.
Main Methods:
- Culturing peripheral blood mononuclear cells (PBMCs) under specific stimulation conditions to generate CIK cells.
- Characterization of CIK cell populations, focusing on the CD3+CD56+ phenotype.
- Analysis of cytotoxicity mechanisms, including Major Histocompatibility Antigen (MHC)-independent recognition and Natural Killer Group 2 Member D (NKG2D) receptor signaling.
Main Results:
- CIK cells demonstrate potent anti-tumor activity against a wide range of cancers.
- Clinical trials indicate the feasibility and efficacy of CIK cell immunotherapy, even in advanced or treatment-refractory cancers.
- The CD3+CD56+ T cells within CIK populations mediate tumor cell killing via MHC-independent pathways involving NKG2D.
Conclusions:
- CIK cell immunotherapy is a viable and effective treatment option for various cancers.
- Further research into CIK cell biology and clinical applications holds significant promise for cancer treatment.
- CIK cell therapy represents a valuable approach in the field of cancer immunotherapy, with ongoing trials exploring its full potential.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
01:27Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K